Stratos Wealth Partners LTD. Has $338,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Stratos Wealth Partners LTD. reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 46.3% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,172 shares of the exchange traded fund’s stock after selling 3,596 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in SPDR S&P Biotech ETF were worth $338,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Sharper & Granite LLC raised its holdings in shares of SPDR S&P Biotech ETF by 15.2% during the 1st quarter. Sharper & Granite LLC now owns 13,883 shares of the exchange traded fund’s stock worth $1,126,000 after buying an additional 1,830 shares in the last quarter. Interchange Capital Partners LLC bought a new position in SPDR S&P Biotech ETF in the first quarter valued at about $217,000. Compass Wealth Management LLC raised its position in SPDR S&P Biotech ETF by 46.0% in the first quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock valued at $51,000 after purchasing an additional 200 shares during the last quarter. Viewpoint Capital Management LLC raised its position in SPDR S&P Biotech ETF by 250.0% in the first quarter. Viewpoint Capital Management LLC now owns 7,000 shares of the exchange traded fund’s stock valued at $568,000 after purchasing an additional 5,000 shares during the last quarter. Finally, Concurrent Investment Advisors LLC raised its position in SPDR S&P Biotech ETF by 3.7% in the first quarter. Concurrent Investment Advisors LLC now owns 8,504 shares of the exchange traded fund’s stock valued at $690,000 after purchasing an additional 300 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 2.7%

Shares of XBI stock opened at $85.91 on Wednesday. The stock has a 50-day moving average of $82.17 and a 200-day moving average of $84.56. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47. The stock has a market cap of $5.04 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.